News | March 30, 2022
Sun Pharma gets exclusive patent licence for Vortioxetine
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
It celebrated its 100th session as LPC-100 in association with Mundial Pharma
The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
Subscribe To Our Newsletter & Stay Updated
